PLASMA AND URINE CARNITINE IN DIABETIC KETOSIS
PLASMA AND URINE CARNITINE IN DIABETIC KETOSIS
复制标题
DOI:
10.2337/diab.28.12.1083
复制
发表时间:
1979-01-01
期刊:
影响因子:
7.7
通讯作者:
HOPPEL, CL
中科院分区:
文献类型:
--
作者:
GENUTH, SM;HOPPEL, CL
Carnitine is an essential factor in fatty acid oxidation and, hence, in ketoacid production. In plasma, therefore, free carnitine, short-chain acylcarnitine, long-chain acylcarnitine, and total carnitine (sum of all 3 fractions) were determined in normal subjects, in diabetics with ketosis and in diabetics in ketoacidosis. Short-chain acylcarnitine (mean .+-. SEM [standard error of the mean]) was significantly higher in ketoacidotic diabetics (31.0 .+-. 4.0 .mu.M) and ketotic diabetics (11.8 .+-. 1.2 .mu.M) than in normals (5.8 .+-. 0.65); long-chain acylcarnitine was significantly higher in ketoacidotic diabetics (8.0 .+-. 1.0 .mu.M) than in ketotic diabetics (20.5 .+-. 3.3 .mu.M) than in ketotic diabetics (31.8 .+-. 2.2 .mu.M) or normals (36.5 .+-. 1.5 .mu.M). Plasma short-chain acylcarnitine correlated positively with blood .beta. hydroxybutyrate in normals (r [correlation coefficient] = 0.69, P < 0.001) but not in either diabetic group. The abnormal distribution in plasma of free carnitine and acylcarnitines in the diabetics was promptly returned toward normal, in parallel with blood .beta. hydroxybutyrate, by insulin treatment. The latter also resulted in a 70% reduction in 24 h urinary excretion of acylcarnitine. These data are consistent with a postulated role for carnitine in diabetic ketogenesis in man.